Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus

Clinical Rheumatology

Volumn 28, Issue 7, 2009, Pages 841-845

  Syuto, Tomoko ^a   Shimizu, Akira ^a   Takeuchi, Yuko ^a   Tanaka, Setsuko ^a   Hasegawa, Michiko ^a   Nagai, Yayoi ^a   Tamura, Atsushi ^a   Ishikawa, Osamu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiphosphatidylserine prothrombin antibody; Neuropsychiatric systemic lupus erythematosus

Indexed keywords

ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; PROTHROMBIN ANTIBODY; RIBOSOME PROTEIN P ANTIBODY; UNCLASSIFIED DRUG;

ACUTE CONFUSION; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NEUROPSYCHIATRY; POLYNEUROPATHY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PHOSPHATIDYLSERINES; PREDICTIVE VALUE OF TESTS; PROTHROMBIN; RIBOSOMAL PROTEINS;

EID: 67349229592     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1123-1     Document Type: Article

References (17)

1. Zandman-Goddard G, Chapman J, Shoenfeld Y (2007) Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 36:297-315
2. Sanna G, Bertolaccini M, Cuadrado M, Laing H, Khamashta M, Mathieu A et al (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985-992
3. Avcin T, Benseler S, Tyrrell P, Cucnik S, Silverman E (2008) A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 59:206-213
4. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
5. Karassa F, Afeltra A, Ambrozic A, Chang DM, Keyser FD, Doria A et al (2006) Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta-analysis. Arthritis Rheum 54:312-324
6. Rheumatol (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599-608
7. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
8. Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y (2004) Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies - co-existence of these antibodies enhances ADP-induced platelet activation in vitro. Thromb Haemost 91:967-976
9. Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y (2006) The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica 91:699-702
10. Nojima J, Masuda Y, Iwatani Y, Kuratsune H, Watanabe Y, Suehisa E et al (2008) Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Rheumatology (Oxford) 47:684-689
11. Hasegawa M, Sato S, Yanaba K, Komura K, Yamazaki M, Takehara K (2004) Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis. Ann Rheum Dis 63:1514-1517
12. Hanly J, McCurdy G, Fougere L, Douglas J, Thompson K (2004) Neuropsychiatric events in systemic lupus erythematosus: Attribution and clinical significance. J Rheumatol 31:2156-2162
13. Sibbitt WJ, Brandt J, Johnson C, Maldonado M, Patel S, Ford C et al (2002) The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29:1536-1542
14. Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ et al (2007) Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study. Arthritis Rheum 56:265-273
15. Khamashta M, Gil A, Anciones B, Lavilla P, Valencia M, Pintado V et al (1988) Chorea in systemic lupus erythematosus: Association with antiphospholipid antibodies. Ann Rheum Dis 47:681-683
16. Ghosh J, Gupta D (2005) Chorea and microphonia as presenting feature of SLE. Indian J Pediatr 72:85
17. Watanabe T, Onda H (2004) Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis. Pediatr Nephrol 19:451-453